Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Resveratrol Has No Effect in Healthy Obese Men, Study Finds
Data raise doubts about its use as a human nutritional supplement in metabolic disorder
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

July 30, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Approves Balloon Device to Treat Obesity

Low Incidence of Diabetic Ketoacidosis With Canagliflozin

Similar Adverse Effects Seen for St. John's Wort, Fluoxetine

Autism Spectrum Disorder Care Costs Could Top $500B by 2025

Outcomes Equal for Continuous, Intermittent β-Lactams in Sepsis

New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials